These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
191 related items for PubMed ID: 6152645
21. Possible medullary kappa hyperalgesic mechanism. I. A new potential role for endogenous opioid peptides in pain perception. Wu KM, Martin WR, Kamerling SG, Wettstein JG. Life Sci; 1983 Oct 31; 33(18):1831-8. PubMed ID: 6139722 [Abstract] [Full Text] [Related]
22. Analgesic activity of intraspinally administered dynorphin and ethylketocyclazocine. Piercey MF, Varner K, Schroeder LA. Eur J Pharmacol; 1982 May 21; 80(2-3):283-4. PubMed ID: 6125400 [No Abstract] [Full Text] [Related]
23. Modulators of pain in the spinal cord. Jen MF, Lu CH, Huang L, Han JS. NIDA Res Monogr; 1986 May 21; 75():457-60. PubMed ID: 2893278 [Abstract] [Full Text] [Related]
24. Multiple opiate receptors for multiple opioid peptides. Miller RJ. Med Biol; 1982 Feb 21; 60(1):1-6. PubMed ID: 6121959 [No Abstract] [Full Text] [Related]
30. Human psychopharmacology of ketocyclazocine as compared with cyclazocine, morphine and placebo. Kumor KM, Haertzen CA, Johnson RE, Kocher T, Jasinski D. J Pharmacol Exp Ther; 1986 Sep 21; 238(3):960-8. PubMed ID: 3018228 [Abstract] [Full Text] [Related]
31. Investigations on dynorphin structurally-related opioid peptides. I. Impact on nociceptive transmission. II. Regulation of pituitary content. Ferri S, Candeletti S, Cavicchini E, Romualdi P, Spampinato S, Speroni E. Ann Ist Super Sanita; 1988 Sep 21; 24(3):397-402. PubMed ID: 2903708 [No Abstract] [Full Text] [Related]
32. Ethylketocyclazocine and N-cyclopropylmethyl-norazidomorphine are antagonists of morphine-induced analgesia in frog spinal cord. Benyhe S, Wollemann M. Biochem Pharmacol; 1988 Feb 01; 37(3):555-6. PubMed ID: 3276329 [No Abstract] [Full Text] [Related]
35. Morphine- and ketocyclazocine-induced analgesia in the developing rat: differences due to type of noxious stimulus and body topography. Giordano J, Barr GA. Brain Res; 1987 Apr 01; 429(2):247-53. PubMed ID: 3032373 [Abstract] [Full Text] [Related]
36. Blocking mu opioid receptors in the spinal cord prevents the analgesic action by subsequent systemic opioids. Chen SR, Pan HL. Brain Res; 2006 Apr 07; 1081(1):119-25. PubMed ID: 16499888 [Abstract] [Full Text] [Related]
37. Placental kappa binding site : interaction with dynorphin and its possible implication in hCG secretion. Valette A, Tafani M, Porthe G, Pontonnier G, Cros J. Life Sci; 1983 Apr 07; 33 Suppl 1():523-6. PubMed ID: 6141498 [Abstract] [Full Text] [Related]
38. Activation of K-opiate sites by dynorphin in the myenteric plexus. Yoshimura K, Huidobro-Toro JP, Lee NM, Loh HH, Way EL. Adv Biochem Psychopharmacol; 1982 Apr 07; 33():91-8. PubMed ID: 6127009 [No Abstract] [Full Text] [Related]